BRIEF published on 08/27/2025 at 13:34, 3 months 25 days ago CHEPLAPHARM annonce une croissance stable au premier semestre 2025 Croissance Des Revenus Industrie Pharmaceutique CHEPLAPHARM Programme De Transformation Expansion Des Employés
BRIEF published on 08/27/2025 at 13:34, 3 months 25 days ago CHEPLAPHARM Reports Stable Growth in the First Half of 2025 Pharmaceutical Industry Revenue Growth Transformation Program CHEPLAPHARM Employee Expansion
PRESS RELEASE published on 08/27/2025 at 13:29, 3 months 25 days ago CHEPLAPHARM with stable business in the first half of 2025 Cheplapharm AG reports stable business performance in the first half of 2025, with revenue up by 12% and EBITDA up by 24% compared to the second half of 2024 Financial Results Transformation Program Stability Acquisition Opportunities Cheplapharm AG
BRIEF published on 06/26/2025 at 10:36, 5 months 25 days ago L'obligation de 750 millions d'euros de CHEPLAPHARM connaît une forte demande et un prix attractif Obligations Confiance Des Investisseurs Médicaments Flexibilité Financière CHEPLAPHARM
BRIEF published on 06/26/2025 at 10:36, 5 months 25 days ago CHEPLAPHARM's €750M Bond Sees High Demand and Attractive Pricing Pharmaceuticals Investor Confidence Financial Flexibility Bonds CHEPLAPHARM
PRESS RELEASE published on 06/26/2025 at 10:31, 5 months 25 days ago High Demand and Attractive Pricing: CHEPLAPHARM's New 7.125% Bond Multiple Times Oversubscribed CHEPLAPHARM successfully places €750m senior secured notes at 7.125% interest rate, enhancing financial flexibility and extending maturity profile, oversubscribed transaction Senior Secured Notes Oversubscribed Financial Flexibility CHEPLAPHARM 7.125%
BRIEF published on 06/02/2025 at 10:34, 6 months 19 days ago Sandra Schröder Joins CHEPLAPHARM as VP Scientific Pharmaceutical Regulatory Affairs Quality Management CHEPLAPHARM Sandra Schröder
BRIEF published on 06/02/2025 at 10:34, 6 months 19 days ago Sandra Schröder rejoint CHEPLAPHARM en tant que vice-présidente scientifique Pharmaceutique Affaires Réglementaires Gestion De La Qualité CHEPLAPHARM Sandra Schröder
PRESS RELEASE published on 06/02/2025 at 10:29, 6 months 19 days ago Sandra Schröder joins CHEPLAPHARM’S Management Team as VP Scientific Sandra Schröder appointed as VP Scientific at CHEPLAPHARM, responsible for scientific areas globally. Brings 25 years of experience from F. Hoffmann-La Roche AG Pharmaceutical Industry Management CHEPLAPHARM Sandra Schröder VP Scientific
BRIEF published on 01/02/2025 at 09:19, 11 months 19 days ago CHEPLAPHARM nomme Tamás Szóga au poste de vice-président commercial Expansion De La Gestion CHEPLAPHARM Tamás Szóga Vice-président Commercial Stratégie Pharmaceutique
Published on 12/20/2025 at 00:30, 1 day 20 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 22 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 2 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 6 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 7 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/21/2025 at 08:55, 11 hours 44 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 3 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 10 hours ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 22 hours ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 1 day 22 hours ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 21:57, 1 day 22 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 12 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 12 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 13 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 13 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
